Search
Close this search box.
Register
Healthed-White-on-Blue
Search
Close this search box.
Litt, John

A/Prof John Litt AM

GP; Public Health Physician; Associate Professor in the Discipline of General Practice, Flinders University
A/Prof John Litt is a General Practitioner; Public health physician and has been the Associate Professor in the Discipline of General Practice at Flinders University.

His teaching activities focussed on coordinating the teaching of general practice and arranging placement for medical students in the Flinders University Medical Course. His major clinical and research interests are in prevention and its implementation He has over 100 refereed publications (journal articles, book and book chapters) including co authorship of the Australian General Practice Smoking Cessation Guidelines and its updates and the RACGP prevention guidelines.

More from this expert

Coronavirus,Prevention,Medical,Surgical,Masks,And,Hand,Sanitizer,Gel,For
Podcasts iconPodcasts

Influenza Update for 2022

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

feature-image-e1512457124620
Monographs iconMonographs

Update on Herpes Zoster

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

feature-image-e1512457124620

Update on Herpes Zoster

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

By A/Prof John Litt AM, Prof Tony Cunningham AO, Prof Paul Van Buynder
Monographs iconMonographs
Prof John Litt Still Image_bright

The first cell culture influenza vaccine available in Australia

In this Product Explainer, A/Prof John Litt AM, Public Health Physician explains the differences between the “traditional” egg-based influenza vaccines and the potential advantages of the first cell culture based influenza vaccine available in Australia (5 mins).

By A/Prof John Litt AM
Videos iconVideos
Coronavirus,Prevention,Medical,Surgical,Masks,And,Hand,Sanitizer,Gel,For

Influenza Update for 2022

Some ‘basic’ influenza epidemiology, what happened in 2021 and what to expect in 2022, what's new with cell culture influenza vaccines and high dose influenza vaccines, and importance of vaccination rates

By A/Prof John Litt AM
Podcasts iconPodcasts
Diagnostic,Form,With,Diagnosis,Shingles,And,Pills.

Shingles vaccination – Frequently asked questions answered!

An overview on the zostavax vaccine uptake in Australia, the recombinant zoster vaccine, and the burden of morbidity.

By A/Prof John Litt AM
Podcasts iconPodcasts
Edited.00_00_04_08.Still004

Herpes Zoster vaccine in Australia: Take home messages for GPs

In this Product Explainer, Public Health Physician A/Prof John Litt AM will provide a rapid update on the recombinant (ie non-live) Herpes Zoster vaccine and outline who it is currently indicated for (10 mins).

By A/Prof John Litt AM
Videos iconVideos
AProf John Litt

Influenza vaccines for older adults in the 2023 influenza season

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins). This product explainer is supported by Seqirus

By A/Prof John Litt AM
Videos iconVideos
shutterstock_1946857264(1)

Long COVID: Current research on risk factors, pathophysiology, and emerging treatments

In this podcast, listen to Dr David Lim interview Prof Brendan Crabb as they establish why Long COVID is a large and growing concern as new insights emerge at great speed, and how to assess patients with Long COVID.

By Prof Brendan Crabb AC, A/Prof John Litt AM
Podcasts iconPodcasts

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform